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The new term Flammer syndrome describes a phenotype characterized by the presence of primary vascular
dysregulation together with a cluster of symptoms and signs that may occur in healthy people as well as people with
disease. Typically, the blood vessels of the subjects with Flammer syndrome react differently to a number of stimuli,
such as cold and physical or emotional stress. Nearly all organs, particularly the eye, can be involved. Although the
syndrome has some advantages, such as protection against the development of atherosclerosis, Flammer syndrome
also contributes to certain diseases, such as normal tension glaucoma. The syndrome occurs more often in women
than in men, in slender people than in obese subjects, in people with indoor rather than outdoor jobs, and in
academics than in blue collar workers. Affected subjects tend to have cold extremities, low blood pressure, prolonged
sleep onset time, shifted circadian rhythm, reduced feeling of thirst, altered drug sensitivity, and increased general
sensitivity, including pain sensitivity. The plasma level of endothelin-1 is slightly increased, and the gene expression in
lymphocytes is changed. In the eye, the retinal vessels are stiffer and their spatial variability larger; the autoregulation of
ocular blood flow is decreased. Glaucoma patients with Flammer syndrome have an increased frequency of the
following: optic disc hemorrhages, activated retinal astrocytes, elevated retinal venous pressure, optic nerve
compartmentalization, fluctuating diffuse visual field defects, and elevated oxidative stress. Further research should lead
to a more concise definition, a precise diagnosis, and tools for recognizing people at risk. This may ultimately lead to
more efficient and more personalized treatment.
Keywords: Flammer syndrome, Primary vascular dysregulation, Vasospasm, Cold extremities, Systemic hypotension,
Normal tension glaucoma, Tinnitus, Optic disc hemorrhages, Retinal vein occlusion, Predictive preventive personalized
medicineReview
Introduction
Flammer syndrome [1-4] is a cluster of symptoms and
signs that can occur in healthy people and people with
disease. Its medical relevance lies in the fact that these
subjects react differently to a number of stimuli, such as
cold [5] and physical or emotional stress and that this
aggravated response can induce diseases [6,7]. The term
Flammer syndrome is a medical eponym named after
the Swiss physician Josef Flammer in recognition of his
contribution in this field and of his observations leading
to the definition of such a phenotype.* Correspondence: Katarzyna.Konieczka@usb.ch
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unless otherwise stated.The purpose of this position paper is to summarize
current knowledge about the syndrome and to outline
future directions for research. The goal is not a copious
description of details, but instead a concise overview of
Flammer syndrome. For more detailed information on
primary vascular dysregulation, including references for
original publications, we refer to recent comprehensive
reviews [6,7]. The basic aspects of blood flow particu-
larly in the eye are described in textbooks [8-10].Terminology
The term Flammer syndrome complements and partly
replaces other historical notions briefly described here.
Vasospasm represents reversible disproportionate con-
striction of arteries that causes a temporary shortage of
blood supply in the corresponding organ or a part of it.
Vasospasm has been known in medicine for decades, e.g.s is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Symptoms of Flammer syndrome
Symptoms of Flammer syndrome Frequency
Cold hands and/or feet +++
Long sleep onset time ++
Reduced feeling of thirst ++
Increased sensitivity, e.g.
Increased response to certain drugs ++
Increased smell sensation ++
Increased pain sensation +
Increased high altitude sensitivity +
Increased meteorosensitivity +
Increased sensitivity to vibration ++





+++, often; ++, usually; +, sometimes.
Table 2 Signs of Flammer syndrome
Signs of Flammer syndrome Frequency
Skin temperature redistribution (distal extremities are
colder; trunk is warmer)
+++
Increased skin temperature inhomogeneity under
emotional stress (up to reversible red and white skin
blotches)
++
Low blood pressure; blood pressure drops especially
at night
+++
Low body mass index ++
Nailfold capillaroscopy
Reduced blood flow velocity ++
Prolonged flow cessation after cold provocation +++
Hemorrhages +
Silent myocardial ischemia +
Altered activity of the autonomic nervous system
(beat-to-beat variation)
++
Slightly elevated plasma endothelin-1 level ++
Altered gene expression (measured in lymphocytes) +++
+++, often; ++, usually; +, sometimes.
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Spasm in diseased vessels or after organ transplantations
are not discussed here. Spasm also can occur in morpho-
logically healthy vessels. If spasm is present in several
organs of the same subject simultaneously or sequentially,
the term vasospastic syndrome [5] is used.
With the advent of better technology for analyzing the
vascular system, it became clear that arterial vasospasm is
only one component of a more general type of dysregula-
tion of arteries, veins, and capillaries. The term vascular
dysregulation [11] encompasses, in addition to pathological
constrictions (spasm), inappropriate vasodilatation, be it
more or less than required. Although the signs and symp-
toms of vascular dysregulation can manifest under baseline
conditions, they are observed in particular when the vascu-
lar system is challenged.
Dysregulation in anatomically healthy vessels can also
occur secondary to other diseases, such as inflammation
in remote organs (secondary vascular dysregulation, SVD
[12]). SVD has been described elsewhere [6] and is not
part of Flammer syndrome. However, if vascular dysregu-
lation occurs in subjects without causing disease, it is
called primary vascular dysregulation (PVD) [6]. The
combination of PVD with a cluster of additional vascular
and nonvascular signs and symptoms was previously
called PVD syndrome. However, to label this entire condi-
tion and to avoid confusion, the term Flammer syndrome
[1-4] was introduced instead.
Flammer syndrome
The Greek word ‘syndrome’ means ‘running together’ and
denotes in medicine a condition characterized by a set of
associated signs and symptoms. In Flammer syndrome,
the primary vascular dysregulation is tied to a characteris-
tic physical and psychological condition and a set of add-
itional symptoms and signs [1,2,6,8] (Tables 1, 2 and 3).
Flammer syndrome occurs in a subset of healthy people.
Although this syndrome might even be protective against
certain diseases such as arteriosclerosis, it predisposes to
other diseases such as normal tension glaucoma, retinal
vein occlusion in patients without classical risk factors, or
even sudden hearing loss [6]. As a matter of course, the
corresponding symptoms or signs can occasionally also be
observed in isolated form, independent from the Flammer
syndrome.
Primary vascular dysregulation
To understand PVD, we will first briefly summarize some
aspects of vascular regulation. Since the demand for blood
supply in organs or tissues varies greatly over time, sophis-
ticated blood flow (BF) regulation is necessary. The vascu-
lar system achieves this on the one hand by adapting
perfusion pressure and on the other hand by changing
local resistance. The latter is a function of the vasculardiameter, which, in turn, is regulated by the tone of the
smooth muscle cells in the arteries, veins, and pericytes of
the capillaries. These contractile cells receive information
from the surrounding tissue, the autonomic nervous sys-
tem, and particularly from the vascular endothelium [9,13].
Insufficient or improper adaption of BF, despite anatom-
ically healthy vessels and the absence of a causative
disease, is termed primary vascular dysregulation. The
harmless red and white blotches on the face and neck of
certain stressed people illustrate the basic characteristics
of PVD: The blood supply to a given organ is transiently
not correctly adapted to the need of this organ. This can
Table 3 Ocular signs of Flammer syndrome
Ocular signs of Flammer syndrome Frequency
In otherwise healthy subjects
Reduced capacity to autoregulate ocular blood flow +++
Correlation between the optic nerve head and
peripheral blood flow
++
Increased stiffness of retinal vessels ++
Higher spatial irregularities in retinal vessels ++
Reduced neurovascular coupling (endotheliopathy) +++
Additional signs in patients with normal tension glaucoma
Optic disc hemorrhages ++
Increased retinal venous pressure ++
Activation of retinal astrocytes ++
Increased blood flow resistance in retroocular vessels ++
Increased oxidative stress +
Optic nerve compartment syndrome +
Fluctuating diffuse visual field defects ++
+++, often; ++, usually; +, sometimes.
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Although in such predisposed people, BF might be normal
or only mildly altered under baseline conditions, yet it can
drastically change in response to stimuli, such as cold [5]
or physical or emotional stress [6].
We only partly know the pathomechanisms of PVD at
present. On the one hand, the autonomic nervous system
is involved; on the other hand, however, the noninner-
vated retinal vessels can also be dysregulated, indicating
the involvement of other regulatory mechanisms, particu-
larly of the vascular endothelial cells [6].
The vascular endothelium is a thin layer of cells lining
the inner parts of arteries, veins, capillaries, and lymphatic
vessels, forming a structural barrier between the vessel's
lumen and the surrounding tissue. This layer is important
for hemostasis, barrier function, immune and inflamma-
tory responses, angiogenesis, and particularly in regulating
the vascular tone. In subjects with PVD, the function of
the endothelium is changed. However, the endotheliopa-
thy in PVD should not be confused with the endothelial
dysfunction observed in diseases such as arteriosclerosis
or diabetes.
Physical and psychological conditions
Flammer syndrome occurs more often in women than in
men, in slender more than in obese subjects, in subjects
with systemic hypotension more than in subjects with
hypertension, in people with indoor jobs more than in
those with outdoor jobs, in academics more than in
blue collar workers, and in Asians more often than in
Caucasians. Most subjects with Flammer syndrome are
physically and mentally particularly active and assiduous,
and successful in their jobs. Although these subjects carrythe syndrome throughout their lives, the symptoms start
to manifest especially during puberty and mitigate with
age, in women specifically a few years after menopause.
Most subjects with Flammer syndrome indicate that one
or both parents suffered from the same syndrome. It is
therefore likely an inherited condition.
Symptoms
Subjects with Flammer syndrome suffer from a number of
symptoms [6] which are summarized in Table 1. The lead-
ing symptoms include cold hands and/or feet, low blood
pressure, prolonged sleep onset time, shifted circadian
rhythm, and reduced feeling of thirst; these subjects are
less thirsty but normally drink enough since they are
aware of the need to drink. As a rule, these subjects are
exceptionally sensitive. This includes aspects such as
increased pain sensitivity but also augmented perception
of thunderstorms or increased ability to smell, boosted re-
sponse to high altitude, and increased vibration sensitivity.
Sensitivity to certain drugs is also increased (e.g. calcium
channel blockers and systemic beta-blockers). Subjects
with Flammer syndrome tolerate these drugs well but only
at lower doses than usually prescribed. Subjects often
conspicuously indicate tinnitus and muscular cramps. If
migraineurs suffer from Flammer syndrome, they often
experience prodromal symptoms, including visual aura,
before the pain attack.
Signs
Subjects with Flammer syndrome typically show a number
of general (Table 2) and ocular (Table 3) signs [6]. The
leading signs include a lower distal temperature (hands,
feet, and cornea), while core temperature is normal or
even slightly elevated. Although the baseline BF velocity in
various organs is either normal or slightly decreased, it
drops significantly when triggered. In nailfold capillaro-
scopy, prolonged blood flow cessation after cold provoca-
tion is observed. Blood pressure is generally low or can
drop when subjects stand up (orthostatic hypotension) or
during sleep (nocturnal over-dipping). As these subjects
age, their blood pressure can normalize or even increase
above normal.
The level of endothelin-1 in the circulating blood is often
slightly increased, and endothelin sensitivity is inversely re-
lated to blood pressure. Gene expression in lymphocytes
(and probably in other cells as well) is quantitatively
altered. The circadian rhythm is delayed by almost 1 h.
Analysis of the heart rate variability reveals an autonomic
imbalance with sympathetic predominance, and the
frequency of silent myocardial ischemia is increased [6].
Under stress, skin temperature becomes more inhomogen-
eous. This can be observed with the help of thermography
and is sometimes so strong that it leads to visible skin
blotches.
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spatial variability larger, and flow-mediated vasodilation is
reduced (manifested as reduced neurovascular coupling).
The autoregulatory responses to an intraocular pressure
(IOP) increase or blood pressure decrease are reduced or
even absent. The altered autoregulation explains why in
such cases ocular blood flow correlates with peripheral
blood flow. Glaucoma patients with Flammer syndrome
have additional signs (Table 3).
Differentiation from other conditions
Several conditions are similar but not identical to Flammer
syndrome [4]. We briefly discuss some of these conditions.
Secondary vascular dysregulation
In certain diseases, affected tissue releases vasoactive
substances, e.g. endothelin-1, into the circulating blood.
This influences remote organs and can lead to vascular
dysregulation, particularly in the optic nerve head [9].
The endothelin-1 plasma level is, e.g. often increased in
multiple sclerosis, optic neuritis, rheumatoid arthritis,
fibromyalgia, or giant cell arteritis [6]. The distinct dif-
ferences between SVD and PVD have already been de-
scribed [6].
Vegetative dystonia
The clinical picture of this not well-defined condition
results from functional disturbances of the autonomic
nervous system. Although in Flammer syndrome the
autonomic nervous system also plays a role, many symp-
toms and signs are independent from it. For example, in
Flammer syndrome, the retinal vessels are dysregulated,
although they are not innervated autonomously.
Raynaud's disease
Flammer syndrome should not be confused with Raynaud's
disease (RD) [2]. RD is more rare and severe. Patients with
RD also respond to cold and psychological stress, but with
a more excessive BF decrease. This leads to severe hypoxia
of the superficial skin, which turns white and blue. When
the BF returns to normal, the skin turns red and throbs or
tingles. The loss of BF can cause sores or tissue death. RD
may also cause nails to become brittle with longitudinal
ridges.
In contrast, the BF disturbance in Flammer syndrome is
less acute, less severe, and less localized. It can sometimes
lead to pale extremities. However, it does not lead to white
fingers or to trophic changes in the extremities. Flammer
syndrome comprises many additional vascular and non-
vascular symptoms and signs not related to RD [2].
The term Raynaud's phenomenon was coined to de-
scribe a similar but weaker entity than Raynaud's disease.
Raynaud's phenomenon can also be primary or secondary.
The symptoms of Raynaud's phenomenon are to someextent similar to those of PVD, but still more severe and
not accompanied with the symptoms and signs of the
Flammer syndrome.
Migraine
Although subjects with Flammer syndrome suffer more
often from migraines (and vice versa), the two entities are
not primarily identical and should not be confused [6].
Patients with migraine also often are sensitive, including
thermal hypersensitivity between attacks. A migraine
attack in a subject with Flammer syndrome often triggers
symptoms such as cold hands. A reduction in neurovascu-
lar coupling during an acute attack has also been reported,
which potentially explains why migraine patients avoid
intense light and noises.
Subjects with Flammer syndrome sometimes (but not
often) suffer from retinal migraine, also called ‘presumed
retinal vasospasm’. A relationship between retinal vaso-
spasm and alterations in the nailfold capillaries was
already described in 1939 [6]. The reversible vasoconstric-
tion in the retina indicates that stimuli for vasoconstric-
tion other than the autonomic nervous system must exist.
Taking neurovascular coupling into consideration, it
seems feasible that the spreading depression acts as a trig-
ger for vasoconstriction [6]. Briefly, migraine and Flammer
syndrome have a few aspects in common but also have
many distinct differences. Obviously, patients can suffer
from both.
Related diseases
Despite many symptoms and signs, most subjects with
Flammer syndrome are healthy people. On the one hand,
they may even be relatively protected against certain dis-
eases such as arteriosclerosis or diabetes type 2 since
metabolic syndrome occurs less frequently in subjects
with low blood pressure, low body mass index, or high
physical activity. On the other hand, however, affected
subjects have an increased risk of certain other diseases
[6], such as normal tension glaucoma [2,8] (see below).
Vascular occlusions normally occur in older patients with
arteriosclerosis. In subjects with Flammer syndrome, vas-
cular occlusions (including Susac syndrome, anterior
ischemic optic neuropathy, and myocardial infarctions)
can occur, though rarely, at a young age and in the ab-
sence of risk factors for arteriosclerosis. This is particularly
true for retinal vein occlusions. Whether some forms of
microvascular angina, such as cardiac syndrome X [14] or
spasm of coronary arteries such as Prinzmetal angina may
be related to Flammer syndrome must be studied since
there are similarities. Subjects with Flammer syndrome
often report tinnitus and sometimes even sudden hearing
loss with mostly good reversibility. Flammer syndrome
can be associated with autoimmune diseases such as mul-
tiple sclerosis or thyroid dysfunction [6]. Patients with
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of Flammer syndrome before they suffered from multiple
sclerosis. We hypothesize that very small ischemic lesions
in youth may trigger autoimmune diseases that manifest
later in life. In micro-infarctions, the dying cells release
molecules normally not exposed to the immune system.
This may induce an immune response. Flammer syndrome
also modifies the phenotype of genetic diseases such as
retinitis pigmentosa or Leber's optic neuropathy [6].
Normal tension glaucoma
Mild but repeated BF decrease, mainly due to disturbed
autoregulation and ocular perfusion pressure fluctuation,
leads to an unstable oxygen supply and therefore to an
increased local mitochondrial oxidative stress [15-18].
This process is a recognized pathophysiological mechan-
ism of glaucomatous optic neuropathy. Generally, patients
who develop glaucomatous damage despite a normal IOP
or patients with progressing glaucomatous damage despite
well-controlled IOP very often suffer from Flammer
syndrome. Although this type of glaucomatous damage is
basically the same as in patients with high IOP, there are
differences. The retinal venous pressure is on the average
higher, splinter hemorrhages occur more often, retinal
astrocytes are more often activated, oxidative stress is
increased, optic nerve compartment syndrome can more
often be detected [6], and the retinal vessels of the optic
nerve head are less shifted to the nasal side [1]. Glaucoma
patients with Flammer syndrome have particularly large
long-term fluctuations of the diffuse component of visual
field defects, which is best observed with the help of a
Bebie curve (Table 3).
Diagnostics
Flammer syndrome suspect is based on classical symp-
toms such as cold hands or feet. Twenty-four-hour blood
pressure monitoring helps find arterial hypotension. The
diagnosis [6,8,10,19] can then be substantiated by special
examinations such as dynamic retinal vessel analysis, nail-
fold capillaroscopy, or quantification of gene expression in
lymphocytes. The gold standard, however, still remains to
be defined.
Treatment
Flammer syndrome is mostly harmless, and therefore,
most subjects require no treatment. However, if the
symptoms are annoying or affected individuals develop
related diseases, we consider treatment as necessary.
The intensity of the treatment depends on the clinical pic-
ture and the individual situation. Although little research
has been conducted on treatment, we can still assist these
patients based on the information available. The treatment
is based on three pillars: (a) lifestyle management, (b) nu-
trition, and (c) drug therapy.Lifestyle management
Most subjects with Flammer syndrome know what trig-
gers their vasospastic episodes; as a consequence, one can
recommend ways to avoid those. These can include ther-
mal protection, prevention of stress, regular sleep, and
regular but not excessive physical activity and moderation
in sports. Autogenic training or yoga can help to relax [6].
Enough adaption time should be taken when going to high
altitude, etc.
Nutrition
The symptoms inversely correlate with body mass index
[6]. We therefore recommend eating enough to avoid
excessive leanness. Fasting periods trigger symptoms [6].
If blood pressure is low, salt and fluid intake can be
increased, particularly in the evening to avoid excessive
nocturnal blood pressure dips. Omega-3 fatty acids, as
those contained in fish, are also recommended [6]. Since
oxidative stress, induced by the unstable oxygen supply,
may increase, particularly in the eye, antioxidative diet is
considered [6,9,10].
Drug treatment
Magnesium [6], a physiological calcium channel blocker
(CCB), reduces the vasoconstrictive effect of endothelin-1
and improves BF regulation [6]. A relatively high dose of
at least 10–20 mmol/day magnesium is needed. The only
side effect observed is diarrhea, which mitigates quickly
when the dose is reduced.
If magnesium is not sufficient to improve vascular regula-
tion, a very low dose of CCB [20], preferably nifedipine or
amlodipine can be added. It is important to keep the dose
low for the following reasons: (1) low doses can have a good
effect on regulating vessels, (2) subjects with Flammer
syndrome have increased drug sensitivity, and (3) in most
cases, a further decrease blood pressure is not desirable.
Before and after CCB therapy is initiated, blood pressure
should be controlled; CCB treatment was recently reviewed
[20]. The combination of magnesium with low-dose CCB
not only improves regulation of blood vessels as observed
with the Dynamic Retinal Vessel Analyzer [7] but also
reduces retinal venous pressure and optic nerve compart-
mentalization [6].
To protect the mitochondria from oxidative stress,
ginkgo biloba [6] can be used at the dose of 120 mg
extract per day. In case of severe arterial hypotension,
low doses of fludrocortisone [6] (0.1 mg twice per week)
can be effective; mineralocorticoids have fewer side ef-
fects than glucocorticoids. Vasoconstrictive drugs should
be avoided.
Conclusions
Although Flammer syndrome is quite prevalent and
mostly benign, it may contribute to the occurrence and
Konieczka et al. The EPMA Journal 2014, 5:11 Page 6 of 7
http://www.epmajournal.com/content/5/1/11progression of potentially serious diseases such as normal
tension glaucoma. At present, we are still in the early stage
of research in this field. The authors suggest the following
steps in order to promote research area:
1. The phenotype should be further characterized,
qualitatively and quantitatively.
2. The underlying pathophysiology should be studied
in more detail, particularly the role of genetics, the
autonomic nerve system, the vascular endothelial
cells, and the mitochondria.
3. The role of environmental factors such as light
exposure or nutrition needs to be established.
4. The relationship between vascular factors and
autoimmune diseases should be studied.
5. The cause of the combination of vascular
dysregulation with nonvascular signs and symptoms
needs to be found.
6. The statistical and causal relationships with related
diseases should be established.
7. The gold standard for diagnosis must be defined.
8. The age-, gender-, and race-dependent prevalence
should be studied.
The present treatment modalities are of limited value
and not yet based on well-controlled studies. Vitamin D,
for example, may play a role but has not been studied yet.
Developing novel drug targets and more efficient treat-
ment approaches is desirable [21]. Establishing the risk for
related diseases may lead to predictive and preventive
diagnostics, and treatment tailored to the person.
Abbreviations
BF: Blood flow; CCB: Calcium channel blocker; IOP: Intraocular pressure;
PVD: Primary vascular dysregulation; RD: Raynaud's disease; SVD: Secondary
vascular dysregulation.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
KK wrote the manuscript and all coauthors read and corrected the first
version. All authors read and approved the final manuscript.
Authors' information
Dr. KK is a glaucoma specialist from the Department of Ophthalmology,
University of Basel, Switzerland. Prof. RR is Shelley and Steven Einhorn
Distinguished Chair and is the Surgeon Director and Chief of the Glaucoma
Services, Einhorn Clinical Research Center, New York Eye and Ear Infirmary of
Mount Sinai, New York, NY, USA. He is also the Founder, Medical Director,
and Chairman in the Scientific Advisory Board of the Glaucoma Foundation.
CET is Professor and Chairman, Clinica Oculistica, Di.N.O.G.M.I. Univestity of
Genova, IRCCS Azienda Ospedaliera Universitaria San Martino – IST, Genova,
Italy. Prof. DMK is a glaucoma specialist from the Department of
Ophthalmology, Seoul National University, Seoul, Korea. Prof. MSK is a
glaucoma specialist from the Department of Ophthalmology, University of
Ulsan, Seoul, Korea. Prof. AG is the Chief of Internal Medicine and Cardiology
Department in Ospedale San Giovanni, Bellinzona and is a Professor at the
University of Zürich, Switzerland. Prof. OG is a Secretary-General of the
European Association for Predictive, Preventive and Personalised Medicine
(with special interest in molecular diagnostics) and is from the Departmentof Radiology, Friedrich-Wilhelms-University of Bonn, Germany. Prof. CE is a
glaucoma specialist and the Medical Director of Eye Clinic Wittenbergplatz,
Berlin, Germany. Prof. HAR is the Head of Glaucoma Department and Head
of Fuchs Laboratory, Department of Ophthalmology, SALK/Paracelsus Medical
University, Salzburg, Austria. Dr. TK is an ophthalmologist with special interest in
ocular blood flow and medical retina, Ophthalmology Department, Osaka
Medical College, Takatsuki, Japan. Prof. NK is the Head of the Diagnostic and
Glaucoma Department, University of Medical and Biological Agency of Russian
Federation, Moscow, Russian Federation. Prof. KY is the President-elect of the
Chinese Ophthalmological Society and Chief of the Eye Center of Second
Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China
(special interests are cataract and glaucoma).
Acknowledgements
Authors thank Prof. Josef Flammer for proofreading the manuscript.
Author details
1Department of Ophthalmology, University of Basel, Mittlere Strasse 91, 4031
Basel, Switzerland. 2Einhorn Clinical Research Center, New York Eye and Ear
Infirmary of Mount Sinai, New York, NY 10003, USA. 3Clinica Oculistica, Di.N.O.
G.M.I., University of Genova, 16132 Genova, Italy. 4Department of
Ophthalmology, Seoul National University, Seoul 110-744, Korea.
5Department of Ophthalmology, University of Ulsan, Seoul 680-749, Korea.
6Department of Internal Medicine and Cardiology, Ospedale San Giovanni,
6500 Bellinzona, Switzerland. 7Department of Radiology,
Friedrich-Wilhelms-University of Bonn, 53113 Bonn, Germany. 8Eye Clinic
Wittenbergplatz, 10789 Berlin, Germany. 9Department of Ophthalmology,
SALK/Paracelsus Medical University, 5020 Salzburg, Austria. 10Department of
Ophthalmology, Osaka Medical College, Takatsuki 569-8686, Japan.
11Department of Diagnostic and Glaucoma, University of Medical and
Biological Agency of the Russian Federation, 105077 Moscow, Russian
Federation. 12Eye Center of Second Affiliated Hospital, Zhejiang University
College of Medicine, Hangzhou 310009, China.
Received: 24 May 2014 Accepted: 23 June 2014
Published: 8 July 2014
References
1. Konieczka K, Fränkl S: Primäre vaskuläre Dysregulation und Glaukom
[Primary vascular dysregulation and glaucoma]. Z Prakt Augenheilkd 2013,
34:207–215.
2. Konieczka K, Frankl S, Todorova MG, Henrich PB: Unstable oxygen supply
and glaucoma. Klin Monbl Augenheilkd 2014, 231(2):121–126.
3. Konieczka K, Choi HJ, Koch S, Schoetzau A, Küenzi D, Kim DM: Frequency of
symptoms and signs of primary vascular dysregulation in Swiss and
Korean populations. Klin Monbl Augenheilkd 2014, 231(4):344–7.
4. Brähler E, Hoefert H-W: Lexikon der Modernen Krankheiten. Berlin: Medizinisch
Wissenschaftliche Verlagsgesellschaft; 2014.
5. Saner H, Wurbel H, Mahler F, Flammer J, Gasser P: Microvasculatory
evaluation of vasospastic syndromes. Adv Exp Med Bio 1987, 220:215–218.
6. Flammer J, Konieczka K, Flammer AJ: The primary vascular dysregulation
syndrome: implications for eye diseases. EPMA J 2013, 4(1):14.
7. Flammer J, Konieczka K, Bruno RM, Virdis A, Flammer AJ, Taddei S: The eye
and the heart. Eur Heart J 2013, 34(17):1270–1278.
8. Flammer J: Glaukom. 3, überarbeitete Auflage ed. Hans Huber Verlag: Bern;
2009.
9. Flammer J, Mozaffarieh M, Bebie H: Basic Sciences in Ophthalmology—Physics
and Chemistry. Heidelberg: Springer; 2013.
10. Mozaffarieh M, Flammer J: Pocket Reference to Ocular Blood Flow and
Glaucomatous Optic Neuropathy. Heidelberg: Springer; 2009.
11. Flammer J: The vascular concept of glaucoma. Surv Ophthalmol 1994,
38(Suppl):S3–S6.
12. Flammer J, Pache M, Resink T: Vasospasm, its role in the pathogenesis of
diseases with particular reference to the eye. Prog Retin Eye Res 2001,
20(3):319–349.
13. Lekakis J, Abraham P, Balbarini A, Blann A, Boulanger CM, Cockcroft J,
Cosentino F, Deanfield J, Gallino A, Ikonomidis I, Kremastinos D, Landmesser U,
Protogerou A, Stefanadis C, Tousoulis D, Vassalli G, Vink H, Werner N, Wilkinson I,
Vlachopoulos C: Methods for evaluating endothelial function: a position
statement from the European Society of Cardiology Working Group on
Peripheral Circulation. Eur J Cardiovasc Prev R 2011, 18(6):775–789.
Konieczka et al. The EPMA Journal 2014, 5:11 Page 7 of 7
http://www.epmajournal.com/content/5/1/1114. Camici PG, Crea F: Coronary microvascular dysfunction. New Engl J Med 2007,
356(8):830–840.
15. Delaney Y, Walshe TE, O'Brien C: Vasospasm in glaucoma: clinical and
laboratory aspects. Optometry Vision Sci 2006, 83(7):406–414.
16. Choi J, Jeong J, Cho HS, Kook MS: Effect of nocturnal blood pressure
reduction on circadian fluctuation of mean ocular perfusion pressure: a
risk factor for normal tension glaucoma. Inv Ophth Vis Sci 2006,
47(3):831–836.
17. Choi J, Kim KH, Jeong J, Cho HS, Lee CH, Kook MS: Circadian fluctuation
of mean ocular perfusion pressure is a consistent risk factor for
normal-tension glaucoma. Invest Ophth Vis Sci 2007, 48(1):104–111.
18. Choi J, Lee JR, Lee Y, Lee KS, Na JH, Han S, Kook MS: Relationship between
24-hour mean ocular perfusion pressure fluctuation and rate of
paracentral visual field progression in normal-tension glaucoma.
Invest Ophth Vis Sci 2013, 54(9):6150–6157.
19. Yeghiazaryan K, Flammer J, Golubnitschaja O: Predictive molecular
profiling in blood of healthy vasospastic individuals: clue to targeted
prevention as personalised medicine to effective costs. EPMA J 2010,
1(2):263–272.
20. Mozaffarieh M, Konieczka K, Flammer J: Calcium channel blockers: their
use in normal tension glaucoma. Expert Rev Ophthalmol 2010, 5(5):9.
21. Golubnitschaja O, Yeghiazaryan K, Flammer J: Glaucomatous optic
neuropathy: risk assessment and potential targets for effective
prevention and treatments tailored to the patient. In Neurodegenerative
Diseases: Integrative PPPM Approach as the Medicine of the Future. Edited by
Mandel S. Dordrecht: Springer; 2013:187–201.
doi:10.1186/1878-5085-5-11
Cite this article as: Konieczka et al.: Flammer syndrome. The EPMA
Journal 2014 5:11.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
